Agilent Technologies Agrees to Acquire Dako for US$2.2 B in its Largest Deal to Date

Abstract

Agilent Technologies has agreed to buy the Danish cancer diagnostics company Dako, which is currently owned by the Swedish private equity group EQT Partners, for US$2.2 B. The acquisition, which represents the largest deal in Agilent’s history, is the company’s latest attempt to expand its life sciences business and will complement its existing diagnostics portfolio.